Upon binding of theB7.1 or PD-L1 molecules expressed on either tumor cells or macrophages in the TME to the CTLA-4 or PD1 receptors on activated T-cells, the T-cell responses are inhibited and regressed [66]. The gene discussed is CD274; the disease is neoplasm.